期刊
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.703583
关键词
alternative proteins; glioblastoma; LncRNA-long noncoding RNA; SEPs; ncRNA (noncoding RNA); brain cancer; mass spectrometry-LC-MS; MS
Glioblastoma, the most common brain cancer in adults, has a median survival time of 15 months with near total resection, radiotherapy, and temozolomide treatment. Research has shown that variations in non-coding ribonucleic acid expression play a role in tumor processes, potentially impacting protein-protein interactions and signaling pathways in glioblastoma.
Glioblastoma is the most common brain cancer in adults. Nevertheless, the median survival time is 15 months, if treated with at least a near total resection and followed by radiotherapy in association with temozolomide. In glioblastoma (GBM), variations of non-coding ribonucleic acid (ncRNA) expression have been demonstrated in tumor processes, especially in the regulation of major signaling pathways. Moreover, many ncRNAs present in their sequences an Open Reading Frame (ORF) allowing their translations into proteins, so-called alternative proteins (AltProt) and constituting the ghost proteome. This neglected world in GBM has been shown to be implicated in protein-protein interaction (PPI) with reference proteins (RefProt) reflecting involvement in signaling pathways linked to cellular mobility and transfer RNA regulation. More recently, clinical studies have revealed that AltProt is also involved in the patient's survival and bad prognosis. We thus propose to review the ncRNAs involved in GBM and highlight their function in the disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据